000			04228nam a22004335i 4500
999			_c368791 _d368791 _x1
001			368791
003			ES-MaUEC
005			20230102121808.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			220211s2022 sz | s |||| 0|eng d
020			_a9783030899189
024	7		_a10.1007/978-3-030-89918-9 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC270.8 _b2022 EB
100	1		_aCyr, Claude _eautor _9683670
245	1	0	_aCannabis and Cannabinoid-Based Medicines in Cancer Care : _bA Comprehensive Guide to Medical Management _cby Claude Cyr, Mellar P. Davis, Danial Schecter, Paul Daeninck
250			_aFirst edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XXVII, 308 páginas) _b8 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aOverview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry.
520			_aThe use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis' disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.
988			_aSpringer_Medicine_2022
650		7	_2embne _9174085 _aCáncer _xTratamiento
650		7	_2embne _9262120 _aCannabis _xUso terapéutico
700	1		_aDavis, Mellar P. _eautor
700	1		_aSchecter, Danial _eautor
700	1		_aDaeninck, Paul _eautor
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-89918-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2022 _dz _eu _zSI